7Baggers
 Crinetics Pharmaceuticals Rings the Opening Bell  Nasdaq Tue, 30 Sep 2025 13:15:00 GMT
 Crinetics stock price target raised to $87 from $73 at Oppenheimer  Investing.com Tue, 30 Sep 2025 10:21:00 GMT
 Crinetics wins FDA approval for acromegaly therapy  MSN Mon, 29 Sep 2025 04:45:58 GMT
 crinetics price target raised to $77 from $65 at morgan stanley  TipRanks Sun, 28 Sep 2025 20:56:25 GMT
 Is Crinetics Pharmaceuticals Stock a Buy?  The Motley Fool Sun, 28 Sep 2025 12:30:00 GMT
 Crinetics Pharmaceuticals Stands Out Among Top Nasdaq Stocks  Kalkine Media Sat, 27 Sep 2025 19:44:00 GMT
 crinetics wins fda approval for acromegaly therapy  MSN Sat, 27 Sep 2025 14:23:56 GMT
 crinetics wins fda nod for a first-of-its-kind oral drug  Finimize Sat, 27 Sep 2025 01:09:30 GMT
 Crinetics Pharmaceuticals’ Recent FDA Win: What Investors Need to Know  timothysykes.com Fri, 26 Sep 2025 21:03:00 GMT
 September 26, 2025  PharmExec Fri, 26 Sep 2025 20:58:09 GMT
 Biotech Scores Approval For Growth Disorder Drug; Shares Surge  Investor's Business Daily Fri, 26 Sep 2025 20:22:00 GMT
 crinetics (crnx) sees significant stock surge of 25.7%  GuruFocus Fri, 26 Sep 2025 16:37:14 GMT
 Crinetics Pharmaceuticals (CRNX) Surges After FDA Approval for A  GuruFocus Fri, 26 Sep 2025 15:38:55 GMT
 Crinetics’ Palsonify wins acromegaly approval  The Pharma Letter Fri, 26 Sep 2025 15:33:08 GMT
 Room for growth in acromegaly as Crinetics’ Palsonify cleared  BioWorld MedTech Fri, 26 Sep 2025 15:00:00 GMT
 crinetics (crnx) stock surges over 21%  GuruFocus Fri, 26 Sep 2025 14:41:05 GMT
 Crinetics' daily acromegaly pill earns FDA nod for first-line use  FirstWord Pharma Fri, 26 Sep 2025 13:52:30 GMT
 crinetics stock price target raised to $77 from $65 at morgan stanley  Investing.com Fri, 26 Sep 2025 12:53:48 GMT
 crinetics’ daily acromegaly pill earns fda nod for first-line use  FirstWord Pharma Fri, 26 Sep 2025 12:40:31 GMT
 Crinetics Pharmaceuticals (CRNX) Secures U.S. Approval for Acrom  GuruFocus Fri, 26 Sep 2025 12:03:17 GMT
 crinetics stock rating reiterated at overweight by cantor fitzgerald  Investing.com Fri, 26 Sep 2025 11:59:28 GMT
 crinetics stock price target raised to $85 from $65 at jones trading  Investing.com Fri, 26 Sep 2025 11:56:05 GMT
 Crinetics Pharmaceuticals Stock Soars on FDA Approval  TipRanks Fri, 26 Sep 2025 11:34:36 GMT
 Crinetics wins FDA nod for acromegaly therapy (CRNX:NASDAQ)  Seeking Alpha Fri, 26 Sep 2025 10:53:02 GMT
 Crinetics Pharmaceuticals Gains FDA Approval for PALSONIFY  TipRanks Fri, 26 Sep 2025 10:39:13 GMT
 Baird raises Crinetics stock price target to $62 on Palsonify approval  Investing.com Fri, 26 Sep 2025 09:51:02 GMT
 crinetics price target raised to $143 from $86 at citizens jmp  TipRanks Fri, 26 Sep 2025 09:20:56 GMT
 fda approves crinetics’ once-daily oral acromegaly treatment by investing.com  Investing.com Nigeria Fri, 26 Sep 2025 03:22:37 GMT
 us fda approves crinetics' oral pill for rare hormone disorder  ET Pharma Fri, 26 Sep 2025 02:03:37 GMT
 FDA Approves Crinetics’ Once-Daily Acromegaly Treatment  BioSpace Fri, 26 Sep 2025 00:12:27 GMT
 Crinetics Ready To Launch First Once-Daily Oral Acromegaly Drug, Palsonify  insights.citeline.com Thu, 25 Sep 2025 22:36:55 GMT
 fda approves crinetics' (crnx) palsonify for acromegaly treatmen  GuruFocus Thu, 25 Sep 2025 22:10:32 GMT
 fda approves crinetics’ once-daily oral acromegaly treatment  Investing.com Thu, 25 Sep 2025 21:47:32 GMT
 jp morgan lowers price target for crnx while maintaining overwei  GuruFocus Wed, 24 Sep 2025 13:18:16 GMT
 Crinetics Pharmaceuticals Stock Set to Climb Higher  TipRanks Tue, 23 Sep 2025 07:00:00 GMT
 9 of the fastest-growing biotech stocks under $10 billion  TIKR.com Sat, 13 Sep 2025 07:00:00 GMT
 ctswc25: the future of clinical trial supply hinges on risk management  Yahoo Finance Wed, 10 Sep 2025 07:00:00 GMT
 published on: 2025-09-05 06:13:40  Newser Fri, 05 Sep 2025 11:13:40 GMT
 published on: 2025-09-03 23:00:34  Newser Thu, 04 Sep 2025 04:00:34 GMT
 published on: 2025-09-03 08:54:39  Newser Wed, 03 Sep 2025 13:54:39 GMT
 crinetics pharmaceuticals soars 10.36% on bullish outlook  AInvest Wed, 03 Sep 2025 08:45:47 GMT
 Crinetics: Low Expectations As The PDUFA Clock Ticks To Zero  Seeking Alpha Wed, 03 Sep 2025 07:00:00 GMT
 published on: 2025-09-02 06:24:06  Newser Tue, 02 Sep 2025 11:24:06 GMT
 published on: 2025-09-01 15:42:21  Newser Mon, 01 Sep 2025 20:42:21 GMT

Crinetics Pharmaceuticals, Inc
(NASDAQ:CRNX) 

CRNX stock logo

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin recept...

Founded: 2008
Full Time Employees: 68
Founder: R. Scott Struthers, Stephen F. Betz, Ana Kusnetzow, and Yun-Fei Zhu 
CEO: R. Scott Struthers  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends